SEC Form 4 · accession 0001209191-16-115686
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · PACB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Michael Phillips
Officer — SVP, Research & Development
Period of report
Apr 25, 2016
Accepted (ET)
Apr 26, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001299130
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2016 | M | 20,000 | $1.96 | A | 201,449 | D | |
| Common StockF2 | Apr 25, 2016 | S | 20,000 | $10.286 | D | 181,449 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.96 | Apr 25, 2016 | M | 20,000 | D | — | Jun 21, 2017 | Common Stock | 20,000 | 17,500 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2This is the weighted average price of the shares sold, which ranged from $10.02 to $10.61 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3100% of the shares subject to the option are fully vested and exercisable.